DOI QR코드

DOI QR Code

Safety of Saccharin and Its Current Status of Regulation in the World

삭카린의 안전성과 각국의 관리 현황

  • Kim, Jeong-Weon (Department of Food Engineering, Dankook University) ;
  • Baek, Hyung-Hee (Department of Science and Technology Education for Life, Seoul National University of Education)
  • 김정원 (단국대학교 식품공학과) ;
  • 백형희 (서울교육대학교 생활과학교육과)
  • Received : 2011.09.29
  • Accepted : 2011.10.31
  • Published : 2011.12.31

Abstract

Saccharin was reported to cause urinary bladder cancer in male rats when fed at high doses in a two-generation study, which led to a ban on the use of saccharin in Canada. However, no carcinogenic effect has been observed in other animal experiments conducted with mice, hamsters, or monkeys. Furthermore, numerous epidemiological studies have indicated that there was no relationship between saccharin consumption and the risk of bladder cancer in the human population. Sodium saccharin produces urothelial bladder tumors in rats by the formation of a urinary calcium phosphatecontaining precipitate, which is not relevant to humans because of critical interspecies difference in urine composition. Consequently, in 1999 IARC (International Agency for Research on Cancer) concluded that saccharin and its salts cannot be classified as to their carcinogenicity in humans. In 2010, the EPA (Environmental Protection Agency) of the United States removed saccharin from its list of hazardous substances. It is expected that the use of saccharin in foods might be expanded because saccharin is currently considered safe.

Keywords

References

  1. Whitehouse CR, Boullata J, McCauley LA. The potential toxicity of artificial sweeteners. AAOHN J. 56: 251-259 (2008) https://doi.org/10.3928/08910162-20080601-02
  2. Weihrauch MR, Diehl V. Artificial sweeteners-do they bear a carcinogenic risk? Ann. Oncol. 15: 1460-1465 (2004) https://doi.org/10.1093/annonc/mdh256
  3. Ellwein LB, Cohen SM. The health risks of saccharin revisited. Crit. Rev. Toxicol. 20: 311-326 (1990) https://doi.org/10.3109/10408449009089867
  4. Cohen SM, Arnold LL, Emerson JL. Safety of saccharin. Agro-Food 19: 24-28 (2008)
  5. Kroger M, Meister K, Kava R. Low-calorie sweeteners and other sugar substitutes: A review of the safety issues. Compr. Rev. Food Sci F. 5: 35-47 (2006) https://doi.org/10.1111/j.1541-4337.2006.tb00081.x
  6. Mortensen A. Sweeteners permitted in the European Union: Safety aspects. Scand. J. Food Nutr. 50: 104-116 (2006) https://doi.org/10.1080/17482970600982719
  7. Whysner J, Williams GM. Saccharin mechanistic data and risk assessment: Urine composition, enhanced cell proliferation, and tumor promotion. Pharmacol. Therapeut. 71: 225-252 (1996) https://doi.org/10.1016/0163-7258(96)00069-1
  8. Arnold DL, Krewski D, Munro IC. Saccharin: A toxicological and historical perspective. Toxicology 27: 179-256 (1983) https://doi.org/10.1016/0300-483X(83)90021-5
  9. Bryan GT, Erturk E, Yoshida O. Production of urinary bladder carcinomas in mice by sodium saccharin. Science 168: 1238-1240 (1970) https://doi.org/10.1126/science.168.3936.1238
  10. Tisdel MO, Nees PO, Harris DL, Derse PH. Long term feeding of saccharin in rats. pp. 145-158 In: Symposium: Sweeteners. Inglett GE (ed), AVI Publishing Co., Westport, CT, USA (1974)
  11. Cohen SM, Arnold LL, Cano M, Ito M, Garland EM, Shaw RA. Calcium phosphate-containing precipitate and the carcinogenicity of sodium salts in rats. Carcinogenesis 21: 783-792 (2000) https://doi.org/10.1093/carcin/21.4.783
  12. Cohen SM, Masui T, Garland EM, Arnold LL. Effects of diet on urinary bladder carcinogenesis and cancer prevention. J. Nutr. 127: 8265-8295 (1997)
  13. Cohen SM, Cano M, Garland EM, St John MK, Khachab M, Wehner JM, Arnold LL. Effects of sodium ascorbate, sodium saccharin, and ammonium chloride on the male rat urinary bladder. Carcinogenesis 16: 2743-2750 (1995) https://doi.org/10.1093/carcin/16.11.2743
  14. Cohen SM, Anderson TA, De Oliveira LM, Arnold LL. Tumorigenicity of sodium ascorbate in male rats. Cancer Res. 58: 2557-2561 (1998)
  15. Cohen SM, Cano M, Garland EM, St John MK, Arnold LL. Urinary and urothelial effects of sodium salts in male rats. Carcinogenesis 16: 343-348 (1995) https://doi.org/10.1093/carcin/16.2.343
  16. Cohen SM. Role of urinary physiology and chemistry in bladder carcinogenesis. Food Chem. Toxicol. 33: 715-730 (1995) https://doi.org/10.1016/0278-6915(95)00040-9
  17. Amstrong B, Doll R. Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharin consumption. Brit. J. Prev. Soc. Med. 28: 233-240 (1974)
  18. Amstrong B, Doll R. Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits. Brit. J. Prev. Soc. Med. 29: 73-81 (1975)
  19. Amstrong B, Lea AJ, Adelstein AM, Donovan JW, White GC, Ruttle S. Cancer mortality and saccharin consumption in diabetics. Brit. J. Prev. Soc. Med. 30: 151-157 (1976)
  20. Burbank F, Fraumeni JF. Synthetic sweetener consumption and bladder cancer trends in the United States. Nature 227: 296-297 (1970) https://doi.org/10.1038/227296a0
  21. Morgan RW, Jain MG. Bladder cancer: Smoking, beverages, and artificial sweeteners. Can. Med. Assoc. J. 111: 1067-1070 (1974)
  22. Morrison AS, Verhoek WG, Leck I, Aoki K, Ohno Y, Obata K. Artificial sweeteners and bladder cancer in Manchester, UK and Nagoya Japan. Brit. J. Cancer 45: 332-336 (1982) https://doi.org/10.1038/bjc.1982.59
  23. Cartwright RA, Adib R, Glashan R, Gray BK. The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologies. Carcinogenesis 2: 343-346 (1981) https://doi.org/10.1093/carcin/2.4.343
  24. IARC. Saccharin. Vol. 22, pp. 111-185. In: IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. International Agency for Research on Cancer, Lyon, France (1980)
  25. IARC. Saccharin (Group 2B). Supplement 7, pp. 334-339. In: IARC Monographs on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, Lyon, France(1987)
  26. IARC. Saccharin and its salt. Vol. 73, pp. 517-624. In: IARC Monographs on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, Lyon, France (1999)
  27. Munro IC, Moodie CA, Krewski D, Grice HC. A carcinogenicity study of commercial saccharin in the rat. Toxicol Appl. Pharm. 32: 513-526 (1975) https://doi.org/10.1016/0041-008X(75)90116-7
  28. Chowaniec J, Hicks RM. Response of the rat to saccharin with particular reference to the urinary bladder. Brit. J. Cancer 39: 355-375 (1979) https://doi.org/10.1038/bjc.1979.68
  29. Fukushima S, Arai M, Nakanowatari J, Hibino T, Okuda M, Ito N. Differences in susceptibility to sodium saccharin among various strains of rats and other animal species. Jpn. J. Cancer Res. 74: 8-20 (1983)
  30. Hibino, T, Hirasawa Y, Arai M. Morphologic changes in the urinary bladder and stomach after long-term administration of sodium saccharin in F344 rats. Cancer Lett. 29: 255-263 (1985) https://doi.org/10.1016/0304-3835(85)90135-1
  31. Homma Y, Kondo Y, Kakizoe T, Aso Y, Nagase S. Lack of bladder carcinogenicity of dietary sodium saccharin in analbuminaemic rats, which are highly susceptible to N-nitroso-n-butyl-(4-hydroxybutyl)amine. Food Chem. Toxicol. 29: 373-376 (1991) https://doi.org/10.1016/0278-6915(91)90076-J
  32. Roe FJC, Levy LS, Carter RL. Feeding studies on sodium cyclamate, saccharin and sucrose for carcinogenic and tumor-promoting activity. Food Cosmet. Toxicol. 8: 135-145 (1970) https://doi.org/10.1016/S0015-6264(70)80332-7
  33. Kroes R, Peters PWJ, Berkvens JM, Verschuuren HG, DeVries TH, Van Esch GJ. Long term toxicity and reproduction study (including a teratogenicity study) with cyclamate, saccharin, and cyclohexylamine. Toxicology 8: 285-300 (1977) https://doi.org/10.1016/0300-483X(77)90100-7
  34. Althoff J, Cardesa A, Pour P, Shubik P. A chronic study of artificial sweeteners in Syrian golden hamsters. Cancer Lett. 1: 21-24 (1975)
  35. Coulston F, McChesney EW, Golberg L. Long-term administration of artificial sweeteners to the rhesus monkey (M. Mulatta). Food Cosmet. Toxicol. 13: 297-300 (1975) https://doi.org/10.1016/S0015-6264(75)80030-7
  36. McChesney EW, Coulston F, Benitz KF. Six-year study of saccharin in rhesus monkeys. Toxicol. Appl. Pharm. 41: 164-165 (1977)
  37. Takayama S, Sieber SM, Adamson RH, Thorgeirsson UP, Dalgard DW, Arnold LL, Cano M, Eklund S, Cohen SM. Long-term feeding of sodium saccharin to nonhuman primate: Implications for urinary tract cancer. J. Natl. Cancer Inst. 90: 19-25 (1998) https://doi.org/10.1093/jnci/90.1.19
  38. Taylor JM, Weinberger MA, Friedman L. Chronic toxicity and carcinogenicity to the urinary bladder of sodium saccharin in the in utero-exposed rat. Toxicol. Appl. Pharm. 54: 57-75 (1980) https://doi.org/10.1016/0041-008X(80)90008-3
  39. Arnold DL, Moodie CA, Grice HC, Charbonneau SM, Stavric B, Cillins BT, McGuire PF, Zawidzka ZZ, Munro IC. Long-term toxicity of ortho-toluenesulfonamide and sodium saccharin in the rat. Toxicol. Appl. Pharm. 52: 113-152 (1980) https://doi.org/10.1016/0041-008X(80)90253-7
  40. Schoenig GP, Goldenthal EI, Geil RG, Frith CH, Richter WR, Carlborg FW. Evaluation of the does response and in utero exposure to saccharin in the rat. Food Chem. Toxicol. 23: 475-490 (1985) https://doi.org/10.1016/0278-6915(85)90142-5
  41. Squire RA. Histopathological evaluation of rat urinary bladders from the IRDC two-generation bioassay of sodium saccharin. Food Chem. Toxicol. 23: 491-497 (1985) https://doi.org/10.1016/0278-6915(85)90143-7
  42. Hasegawa R, Cohen SM. The effect of different salts of saccharin on the rat urinary bladder. Cancer Lett. 30: 261-268 (1986) https://doi.org/10.1016/0304-3835(86)90050-9
  43. Jensen OM, Kamby C. Intra-uterine exposure to saccharine and risk of bladder cancer in man. Int. J. Cancer 29: 507-509 (1982) https://doi.org/10.1002/ijc.2910290504
  44. Sina JF, Bean CL, Dysart GR, Taylor VI, Bradley MO. Evaluation of the alkaline elution/rat hepatocyte assay as a predictor of carcinogenic/mutagenic potential. Mutat. Res. 113: 375-391 (1983)
  45. Lutz WK, Schlatter Ch. Saccharin does not bind to DNA of liver or bladder in the rat. Chem. Biol. Interact. 19: 253-257 (1977) https://doi.org/10.1016/0009-2797(77)90036-9
  46. Miyata Y, Hagiwara A, Nakatsuka T, Murasaki G, Arai M, Ito N. Effects of caffeine and saccharin on DNA in the bladder epithelium of rats treated with N-butyl-N-(3-carboxypropyl)-nitrosamine. Chem. Biol. Interact. 29: 291-302 (1980) https://doi.org/10.1016/0009-2797(80)90148-9
  47. Batzinger RP, Ou SYL, Bueding E. Saccharin and other sweeteners: Mutagenic properties. Science 198: 944-946 (1977) https://doi.org/10.1126/science.337489
  48. Stoltz DR, Stavric B. Klassen R. Bendall RD, Craig J. The mutagenicity of saccharin impurities. I. Detection of mutagenic activity. J. Environ. Pathol. Tox. 1: 139-146 (1977)
  49. Ashby J, Styles JA, Anderson D, Paton D. Saccharin: An epigenetic carcinogen/mutagen? Food Cosmet. Toxicol. 16: 95-103 (1978) https://doi.org/10.1016/S0015-6264(78)80187-4
  50. Kristoffersson U. The effect of cyclamate and saccharin on the chromosomes of a Chinese hamster cell line. Hereditas 70: 271-282 (1972)
  51. Chang P, Stacey T. Sodium saccharin: Cytogenic effect on human lymphocytes in vitro. Proc. Natl. Acad. Sci. 48: 50-51 (1974)
  52. Abe S, Sasaki M. Chromosome aberrations and sister chromatid exchanges in chinese hamster cells exposed to various chemicals. J. Natl. Cancer Inst. 58: 1635-1641 (1977)
  53. Wolff S, Rodin B. Saccharin-induced sister chromatid exchanges in chinese hamster and human cells. Science 200: 543-545 (1978) https://doi.org/10.1126/science.644315
  54. Schoenig GP, Anderson RL. The effects of high dietary levels of sodium saccharin on mineral and water balance and related parameters in rats. Food Chem. Toxicol. 23: 465-474 (1985) https://doi.org/10.1016/0278-6915(85)90141-3
  55. Fukushima S, Shibata M, Kurata Y. Tamano S, Masui T. Changes in the urine and scanning electron microscopically observed appearance of the rat bladder following treatment with tumor promoters. Jpn. J. Cancer Res. 77: 1074-1082 (1986)
  56. Fisher MJ, Sakata T, Tibbels TS, Smith RA, Patil K, Khachab M, Johansson SL, Cohen SM. Effect of sodium saccharin and calcium saccharin on urinary parameters in rats fed prolab 3200 or AIN-76 diet. Food Chem. Toxicol. 27: 1-9 (1989) https://doi.org/10.1016/0278-6915(89)90085-9
  57. Garland EM, Kraft PL, Shapiro R, Khachab M, Patil K, Ellwein LB, Cohen SM. Effects of in utero and postnatal sodium saccharin exposure on the nutritional status of the young rat. I. effects at 30 days post-birth. Food Chem. Toxicol. 29: 657-667 (1991) https://doi.org/10.1016/0278-6915(91)90123-O
  58. Cohen SM, Cano M, Earl RA, Carson SD, Garland EM. A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium. Carcinogenesis 12: 1551-1555 (1991) https://doi.org/10.1093/carcin/12.9.1551
  59. Uwagawa S, Saito K, Okuno Y, Kawasaki H, Yoshitake A, Yamada H, Fukusima S. Lack of induction of epithelial cell proliferation by sodium saccharin and sodium L-ascorbate in the urinary bladder of NCI-black-reiter (NBR) male rats. Toxicol. Appl. Pharm. 127: 182-186 (1994) https://doi.org/10.1006/taap.1994.1152
  60. KoSFoST. Encyclopedia of Food Science and Technology. Korean Society of Food Science and Technology, Kwang-Il Mun Hwa Sa. Seoul, Korea pp. 341-342 (2004)
  61. Frederick CB, Dooley KL, Ralph LK, Sheldon WG, Kadlubar FF. The effect of lifetime sodium saccharin dosing on mice initiated with the carcinogen 2-acetylaminofluorene. Toxicol. Sci. 12: 346-357 (1989) https://doi.org/10.1093/toxsci/12.2.346
  62. Ershoff BH, Bajwa GS. Inhibitory effect of sodium cyclamate and sodium saccharin on tumor induction by 2 acetylaminofluorene in rats. Proc. Soc. Exp. Biol. Med. 145: 1293-1297 (1974) https://doi.org/10.3181/00379727-145-37999
  63. Hicks RM, Wakefield J St. J, Chowaniec J. Co-carcinogenic action of saccharin in the chemical induction of bladder cancer. Nature 243: 347-349 (1973) https://doi.org/10.1038/243347a0
  64. Hicks RM, Chowaniec J. The importance of synergy between weak carcinogens in the induction of bladder cancer in experimental animals and humans. Cancer Res. 37: 2943-2949 (1977)
  65. Hicks RM, Wakefield J St. J, Chowaniec J. Evaluation of a new model to detect bladder carcinogens or co-carcinogens; results obtained with saccharin, cyclamate, and cyclophosphamide. Chem. Biol. Interact. 11: 225-233 (1975) https://doi.org/10.1016/0009-2797(75)90101-5
  66. Hicks RM, Wakefield J St. J, Chowaniec J. Impurities in saccharin and bladder cancer. Nature 243: 424 (1973) https://doi.org/10.1038/243424a0
  67. Mohr U, Green U, Althoff J, Schneider P. Syncarcinogenic action of saccharin and sodium cyclamate in the induction of bladder tumours in MNU-pretreated rats. pp. 64-69. In: Health and Sugar Substitutes. Guggenheim B (ed). Karger. Basel, Switzerland (1978)
  68. West RW, Sheldon WG, Gaylor DW, Allen RR, Kadlubar FF. Study of sodium saccharin co-carcinogenicity in the rat. Food Chem. Toxicol. 32: 207-213 (1994) https://doi.org/10.1016/0278-6915(94)90192-9
  69. West RW, Sheldon WG, Gaylor DW, Haskin MG, Delongchamp RR, Kadlubar FF. The effects of saccharin on the development of neoplastic lesions initiated with N-methyl-N-nitrosourea in the rat urothelium. Fund. Appl. Toxicol. 7: 585-600 (1986) https://doi.org/10.1016/0272-0590(86)90108-9
  70. Hooson J, Hicks RM, Grasso P, Chowaniec J. Ortho-toluene sulphonamide and saccharin in the promotion of bladder cancer in the rat. Brit. J. Cancer 42: 129-147 (1980) https://doi.org/10.1038/bjc.1980.211
  71. Nakanishi K, Hirose M, Ogiso T. Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with N-butyl- N-(4-hydroxybutyl)nitrosamine. Jpn. J. Cancer Res. 71: 490-500 (1980)
  72. Nakanishi K, Hagiwara A, Shibata M. Dose response of saccharin in induction of urinary bladder hyperplasias in fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. J. Natl. Cancer Inst. 65: 1005-1010 (1980)
  73. Fukushima S, Uwagawa S, Shirai T, Hasegawa R, Ogawa K. Synergism by sodium L-ascorbate but inhibition by L-ascorbic acid for sodium saccharin promotion of rat two-stage bladder carcinogenesis. Cancer Res. 50: 4195-4198 (1990)
  74. Cohen SM, Arai M, Jacobs JB, Friedell GH. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res. 39: 1207-1217 (1979)
  75. Murasaki G, Cohen SM. Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder. Carcinogenesis 4: 97-99 (1983) https://doi.org/10.1093/carcin/4.1.97
  76. Fukushima S, Friedell GH, Jacobs JB, Cohen SM. Effect of Ltryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res. 41: 3100-3103 (1981)
  77. Imaida K, Wang CY. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats. Cancer Res. 46: 6160-6164 (1986)
  78. Okamura T, Garland EM, Masui T, Sakata T, St. John M, Cohen SM. Lack of bladder tumor promoting activity in rats fed sodium saccharin in AIN-76A diet. Cancer Res. 51: 1778-1782 (1991)
  79. Cohen SM, Ellwein LB, Okamura T, Masui T, Johansson SL, Smith RA, Wehner JM, Khachab M, Chappel CI, Schoenig GP, Emerson JL, Garland EM. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats. Cancer Res. 51: 1766-1777 (1991)
  80. Renwick AG. The intake of intense sweeteners - an update review. Food Addit. Contam. 23: 327-338 (2006) https://doi.org/10.1080/02652030500442532
  81. Chung MS, Suh HJ, Yoo W, Choi SH, Cho YJ, Cho YH, Kim CJ. Daily intake assessment of saccharin, stevioside, D-sorbitol, and aspartame from various processed foods in Korea. Food Addit. Contam. 22: 1087-1097 (2005) https://doi.org/10.1080/02652030500202092
  82. Choi SH. Dietary intake of food additive by Korean population - Sweetener. Final Report. Korea Food & Drug Administrations, Seoul, Korea (2008)
  83. Wikimedia Foundation, Inc. Saccharin. Available from: http:// www.wikipedia.org. Accessed Sep. 20. 2011.
  84. US Environmental Protection Agency. Removal of saccharin from the lists of hazardous constituents and hazardous wastes under RCRA and from the list of hazardous substances under CERCLA. Available from: http://www.epa.gov. Accessed Aug. 15, 2011.
  85. Food and Drug Administration. Code of Federal Regulations. Title 21 section 180.37. Saccharin, ammonium saccharin, calcium saccharin, and sodium saccharin. Available from: http://www. accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm. Accessed Aug. 25, 2011.
  86. Wall Street Journal. Toward a 21st-century regulatory system. Available from: http://online.wsj.com. Accessed Aug. 28, 2011.
  87. Europa. Summaries of EU legislation. Authorised sweeteners. Available from: http://europa.eu/legislation_summaries/other/ 1201069_en.htm. Accessed Aug. 21, 2011.
  88. Health Canada. Sugar substitutes. Available from: http://www.hcsc.gc.ca. Accessed Aug. 28, 2011.
  89. Codex Alimentarius Commission. GSFA online. Available from: http://www.codexalimentarius.net. Accessed Aug. 28, 2011.
  90. Korean Food and Drug Administration. Food Additive Information Room. Available from: http://www.kfda.go.kr. Accessed Aug. 25, 2011.
  91. The Korea International Trade Association. Korea Trade Statistics. Available from: http://stat.kita.net. Accessed April 14, 2011.

Cited by

  1. Consumers Perceptions on Sodium Saccharin in Social Media vol.30, pp.4, 2015, https://doi.org/10.13103/JFHS.2015.30.4.329
  2. Use of Sodium Saccharin and Sucralose in Foodstuffs and the Estimated Daily Intakes of Both Products in Korea vol.45, pp.5, 2013, https://doi.org/10.9721/KJFST.2013.45.5.642